Angulo CR, Umaña AA, Arguedas GE

Language: Spanish
References: 12
Page: 49-52
PDF size: 181.53 Kb.

ABSTRACT

The treatment of psychosis in older people is based on two groups of drugs: antipsychotic and neuroleptics.It is important to know both the characteristics of the drug as well as comorbidity, polypharmacy, social environment of the patient to an appropiate choice of the drug to avoid side effects and interactions.

REFERENCES

1. Agencia Española de Medicamentos y Productos Sanitarios: Comunicación sobre riesgos de medicamentos para profesionales sanitarios. Nuevos datos de seguridad sobre los antipsicóticos olanzapina y risperidona en el tratamiento de pacientes ancianos con psicosis o tratornos de conducta asociados a demencia Nota informativa del 9 de marzo de 2004. Disponible en:http://www.agemed.es/actividad/alertas/usoHumano/seguridad/olanzapina.htm.

2. Agüera, L. Martín, M. Cervilla, J: Psiquiatría Geriátrica. Masson España 2002,199-573.

3. Alarcón R: Psicosis de inicio tardío y su relación con las demencias. Avances en psiquiatría biológica 2005, 106-116.

4. Asociación Americana de Psiquiatría. Psiquiatría Geriátrica: Psychiatric Self Assessment & Review. PSA-R American Psychiatric Association. Edición Española 2000, 45-63.

5. Bullock R, Libretto S: Risperidone in the treatment of psychoses in the elderly: a case report series. European Psychiatry 2002, 96-103.

6. Grossberg G, Manepalli J: The older patient with psychotic symptoms. Psychiatry Service, 2002, 77-113.

7. Karim S, Byrne E: Treatment of psychosis in elderly people. Advances in Psychiatric Treatment 2005, 286-296.

8. Kinon BJ, Stauffer VL, McGuire HC, Kaiser CJ, Dickson RA, Kennedy JS: The effects of antipsychotic drug treatment on prolactin concentration in the elderly. J Am Med Dir Assoc. 2003, 4: 189-94.

9. Marriott R, Neil W, Waddingham S. Antipsicóticos para ancianos con esquizofrenia. La Biblioteca Cochrane Plus. 2006. Número 3.

10. Ritchie CW, Chiu E, Harrigan S, Hall K, Hassett A, Macfarlane S, et al: The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in the elderly patients with schizophrenia. Int J Geriatr Psychiatry 2003, 18: 432-40.

11. Schneeweiss S, Setoguchi S, Brookhart A, Dormuth C, Wang PS: Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. Canadian Medical Association Journal 2007, 176: 627-32.

12. Shink K, Holden K, Yaffe K: Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia. Journal of the American Medical Association 2005, 293: 596-608.